Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 16,012 | 9,328 | 8,040 | 4,598 | 1,864 |
| Operating Income | -16,012 | -9,328 | -8,040 | -4,598 | -1,864 |
| Other Income | 223 | 436 | 215 | 27 | 1 |
| Pre-tax Income | -15,789 | -8,892 | -7,825 | -4,571 | -1,863 |
| Net Income Continuous | -15,789 | -8,892 | -7,825 | -4,571 | -1,863 |
| Net Income | $-15,789 | $-8,892 | $-7,825 | $-4,571 | $-1,863 |
| EPS Basic Total Ops | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 |
| EPS Basic Continuous Ops | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 |
| EPS Diluted Total Ops | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 |
| EPS Diluted Continuous Ops | -1.21 | -0.69 | -0.61 | -0.35 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -1.21 | -0.69 | -0.61 | -0.35 | N/A |
| EBITDA(a) | $-16,008 | $-9,324 | $-8,037 | $-4,594 | $-1,860 |